* Represents mandatory fields
Sept. 15, 2019 - [Drug information] - Oxycontin, an extended released branded version of the generic drug Oxycodone, was originally created and manufactured by Purdue Pharmaceuticals, which is now a subsidiary of Purdue Pharma L.P., incorporated in 1991.
Purdue Pharma’s manufacturing is reported to take place at three sites: Purdue Pharmaceuticals L.P., a plant located in Wilson, North Carolina, the P.F. Laboratories, Inc. in Totowa, New Jersey, and Rhodes Technologies L.P., in Coventry, Rhodes Island. OxyContin is currently distributed throughout the U.S., Canada, and Mexico from the Totowa, New Jersey plant of P.F. Laboratories. Globally, Oxycontin is distributed by Mundipharma International Limited, located in Cambridge, United Kingdom.
In an agreement still under negotiation with several US states, cities and counties (i.e. plaintiffs) in Cleveland, Ohio, USA., as at August 20, 2019, NBC News reported that Purdue Pharma proposes to settle more than 2000 cases that allege that OxyContin manufacture, distribution and marketing, fueled the opioid crisis ravaging several states in the US. Purdue Pharma will pay up to $12 billion to settle those claims.
The settlement would also include a plan for Purdue Pharma to declare Chapter 11 bankruptcy and then reform as a for-profit “public benefit trust,” according to the purported deal, NBC News said.
In effect, Purdue Pharma L.P., as it is currently structured may no longer be the maker of Oxycontin, if the settlement is approved and implemented.
Read more about other Purdue Pharma products
© 2019. Datelinehealth Africa Inc. All rights reserved.